Dr. Mel Chua: Evolution of ChemoRT Trials in Nasopharyngeal Carcinoma: A Hobbit's Journey. Par
0 Views
administrator
07/12/23
In part 1 of his 2 part lecture, Dr. Mel Chua of the National Cancer Center of Singapore reviews the epidemiology of nasopharyngeal cancer and discusses a sequence of major randomized clinical trials that have led to our current standard of care for managing this disease with a multimodality (chemotherapy and radiotherapy) regimen. The moderator/host is Dr. Sana Karam of the University of Colorado. Dr. Chua relates his institution's experience in this domain to the journey of a well known literary figure.
-
Category
Show more
Facebook Comments
No comments found